WHO approves Sinovac Biotech’s coronavirus vaccine for emergency use, the second Chinese treatment to win designation | South China Morning Post

The company joins Sinopharm as a Chinese supplier endorsed by the World Health Organization; the move has the potential to help WHO’s dose-strapped Covax vaccine distribution programme.This content was originally published here.

WHO approves Sinovac Biotech’s coronavirus vaccine for emergency use, the second Chinese treatment to win designation | South China Morning Post

About Manas Halder

I am a Geophysicist by profession and an enthusiastic writer as well.

View all posts by Manas Halder →

One Comment on “WHO approves Sinovac Biotech’s coronavirus vaccine for emergency use, the second Chinese treatment to win designation | South China Morning Post”